Endocrinology Metabolism Clinics of North America

Issue

Alert me when new journal issues are available via or via

Endocrinology and Metabolism Clinics of North America

Volume 35, Supplement 1, Pages 1-24 (December 2006)

Emerging Strategies for the Management of Glycemic Control: The Role of Incretin Enhancers

Sponsored by the Endocrine Society, Supported by an educational grant from Merck & Co., Inc.

Display:

Editorial board
page i
Full-Text PDF (31 KB)

Preface

Emerging Strategies for the Management of Glycemic Control: The Role of Incretin Enhancers
Bernard Zinman
pages 1-2
Full-Text PDF (37 KB)

Type 2 Diabetes Mellitus: Magnitude of the Problem and Failure to Achieve Glycemic Control
Bernard Zinman
pages 3-5
Abstract + References | Full-Text PDF (139 KB)

Islet Dysfunction: An Underlying Defect in the Pathophysiology of Type 2 Diabetes
Richard Pratley
pages 6-11
Abstract + References | Full-Text PDF (632 KB)

Incretin-Based Therapies for Type 2 Diabetes: Clinical Utility
Robert Ratner
pages 12-16
Abstract + References | Full-Text PDF (150 KB)

Emerging Strategies for the Management of Glycemic Control: The Role of Incretin Enhancers: Questions and Answers
Bernard Zinman, Ricard Pratley, Robert Ratner
pages 17-19
Full-Text PDF (58 KB)

Evaluation Form
pages 21-24
Full-Text PDF (65 KB)

Display: